https://www.marketscreener.com/quote/stock/JANONE-INC-65218305/news/JanOne-Earns-US-Patent-for-the-Use-of-its-Novel-Formulation-of-Low-Dose-Naltrexone-Jan123-to-Treat-44723772/?utm_source=telegram&utm_medium=social&utm_campaign=share